Anthera Pharmaceuticals Inc (ANTH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
03-2013 | 12-2012 | 09-2012 | 06-2012 | 03-2012 | |
Operating Expenses | 6,901 | 8,089 | 11,121 | 16,664 | 20,060 |
Operating Income | -6,901 | -8,089 | -11,121 | -16,664 | -20,060 |
Interest Expense | 704 | 797 | 806 | 908 | 843 |
Other Income | 25 | 14,043 | -46 | -28 | -10 |
Pre-tax Income | -7,580 | 5,157 | -11,973 | -17,600 | -20,913 |
Net Income Continuous | -7,580 | 5,157 | -11,973 | -17,600 | -20,913 |
Net Income | $-7,580 | $5,157 | $-11,973 | $-17,600 | $-20,913 |
EPS Basic Total Ops | -3.92 | 20.96 | -11.04 | -27.44 | -32.64 |
EPS Basic Continuous Ops | -3.91 | 20.87 | -11.00 | -27.41 | -32.64 |
EPS Diluted Total Ops | -3.92 | 20.96 | -11.04 | -27.44 | -32.64 |
EPS Diluted Continuous Ops | -3.91 | 20.87 | -11.00 | -27.41 | -32.64 |
EBITDA(a) | $-6,610 | $-7,778 | $-10,859 | $-16,275 | $-19,819 |